Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Public ClinicalTrials.gov record NCT02600741. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Month Randomized, Open-Label Study of Caregiver Psycho-education and Skills Training in Patients Recently Diagnosed With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder and Receiving Paliperidone Palmitate or Oral Antipsychotic Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the overall effect of caregivers receiving a study-provided caregiver psycho-education and skills training program on the number of treatment failures (psychiatric hospitalization, psychiatric emergency room (ER) visit, crisis center visit, mobile crisis unit intervention, arrest/incarceration, and suicide or suicide attempt) in patients under their care during a 12 month period.
Study identification
- NCT ID
- NCT02600741
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 296 participants
Conditions and interventions
Conditions
Interventions
- Caregiver psycho-education and skills training Other
- Caregiver support available at the study site Other
- Paliperidone palmitate Drug
- Chlorpromazine Drug
- Droperidol Drug
- Fluphenazine Drug
- Haloperidol Drug
- Loxapine Drug
- Perphenazine Drug
- Pimozide Drug
- Prochlorperazine Drug
- Thiothixene Drug
- Thioridazine Drug
- Trifluoperazine Drug
- Aripiprazole Drug
- Asenapine Drug
- Clozapine Drug
- Iloperidone Drug
- Olanzapine Drug
- Paliperidone Drug
- Quetiapine Drug
- Risperidone Drug
- Ziprasidone Drug
Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 24, 2015 (Actual)
- Primary completion
- Jul 5, 2018 (Actual)
- Completion
- Jul 5, 2018 (Actual)
- Last update posted
- Jan 23, 2019
2015 – 2018
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Bullhead City | Arizona | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Farmington | Connecticut | — | — |
| Not listed | Lauderdale Lakes | Florida | — | — |
| Not listed | Leesburg | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orange City | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Granite City | Illinois | — | — |
| Not listed | Lombard | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Bloomington | Indiana | — | — |
| Not listed | Lawrenceburg | Indiana | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Mount Pleasant | Michigan | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Lincoln | Rhode Island | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Richland | Washington | — | — |
| Not listed | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02600741, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02600741 live on ClinicalTrials.gov.